Cortexyme is a clinical stage pharmaceutical company developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration. The target has been validated in a number of animal models and Cortexyme is currently testing several potential lead therapeutics in preclinical studies.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

Advanced Neuromodulation Systems, Inc. manufactured, designed, developed and marketed spinal cord stimulation devices. Their products included implantable neurostimulation devices, which deliver electric current directly to targeted nerves and implantable drug pumps. The company was registered in May 3, 1979 and was headquartered in St. Paul, MN.

Pharvaris is a clinical-stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients. By targeting this clinically proven therapeutic target with novel small molecules, we are progressing with new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE) and other B2 receptor-mediated indications. PHA121, Pharvaris’ lead drug candidate, is a novel and potent small-molecule bradykinin B2 receptor antagonist currently under Phase 1 clinical study. The co-founders of Pharvaris include an inventor of icatibant and the leadership from Jerini AG that developed icatibant for the treatment of HAE, now sold by Takeda under the brand name Firazyr®.

Cognosci Inc. was founded in May 2000 to develop anti-inflammatory compounds for the treatment of neuroinflammatory diseases including Multiple Sclerosis, Alzheimer's Disease, and brain bleeding events. Each of these disorders has a pharmacogenomic linkage to the apolipoprotein E (APOE) protein and patients with the APOE-ε4 allele typically suffer worse outcomes. Based on these findings, scientists from Duke University created a novel APOE-based compound that had potent anti-inflammatory and neuroprotective activities.

Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.

Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan.

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Crist��lia Produtos Qu��micos Farmac��uticos Ltda. develops and manufactures pharmaceutical products. It offers its products for algology, primary care practice, dermatology, geriatrics, gynecology, neurology, oncology, orthopedics, psychiatry, rheumatology and urology. The company was founded in 1972 and is headquartered in Itapira, Brazil.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Northstar Neuroscience is a medical device company that develops and commercializes neurostimulation therapies for a broad range of neurological diseases and disorders. Among the company’s major products is the Renova™ Cortical Stimulation System, a device that delivers targeted electrical stimulation to the outer layer of the brain. Northstar Neuroscience was founded in 1999, as Vertis Neuroscience, and is headquartered in Seattle, Washington, USA.

Generex Pharmaceuticals, Inc., a subsidiary of Generex Biotechnology Corp., is a Canadian company located in Toronto, ON, that provides pharmaceutical products.

TransDermal Technologies, Inc. produces a system called Transdermal Delivery System which allows recipients to spray on their medicine. The company was founded on February 12, 1990 and is headquartered in Palm Beach Gardens, FL.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

SBI Pharmaceuticals is a treatment foundation, and treatment methods vary greatly depending on whether or not the cancer has invaded the muscle layer. Non-muscle invasive bladder cancer accounts for approximately half of all cases. Bladder tumour resection (also known as bladder cancer endoscopic resection, TURBT) removes the cancer while leaving the bladder intact.

MSD KK manufactures and distributes conveyor equipment, pressed and welded parts for motorcycles and automobiles. The company was founded in 1929 and is headquartered in Yokohama, Japan.